Bethge WA - Search Results

1

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.

Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D. Bethge WA, et al. Blood. 2010 Sep 9;116(10):1795-802. doi: 10.1182/blood-2010-02-270538. Epub 2010 Jun 7. Blood. 2010. PMID: 20530284 Free article. Clinical Trial.

2

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

Bethge W, Beck R, Jahn G, Mundinger P, Kanz L, Einsele H. Bethge W, et al. Bone Marrow Transplant. 1999 Dec;24(11):1245-8. doi: 10.1038/sj.bmt.1702065. Bone Marrow Transplant. 1999. PMID: 10642816

3

Thyroid toxicity of treatment for Hodgkin's disease.

Bethge W, Guggenberger D, Bamberg M, Kanz L, Bokemeyer C. Bethge W, et al. Ann Hematol. 2000 Mar;79(3):114-8. doi: 10.1007/s002770050565. Ann Hematol. 2000. PMID: 10803932

4

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.

Bethge WA, Wilbur DS, Storb R, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Sandmaier BM. Bethge WA, et al. Blood. 2003 Jun 15;101(12):5068-75. doi: 10.1182/blood-2002-12-3867. Epub 2003 Feb 27. Blood. 2003. PMID: 12609833 Free article.

5

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.

Bethge WA, Hegenbart U, Stuart MJ, Storer BE, Maris MB, Flowers ME, Maloney DG, Chauncey T, Bruno B, Agura E, Forman SJ, Blume KG, Niederwieser D, Storb R, Sandmaier BM. Bethge WA, et al. Blood. 2004 Feb 1;103(3):790-5. doi: 10.1182/blood-2003-07-2344. Epub 2003 Oct 2. Blood. 2004. PMID: 14525766 Free article. Clinical Trial.

6

Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.

Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, Einsele H, Kanz L, Hebart H. Bethge WA, et al. Haematologica. 2005 Nov;90 Suppl:ECR22. Haematologica. 2005. PMID: 16266913

7

Spontaneous thoracic air-leakage syndrome in patients following allogeneic hematopoietic stem cell transplantation: causes, CT-follow up and patient outcome.

Vogel M, Brodoefel H, Bethge W, Faul C, Hartmann J, Schimmel H, Wehrmann M, Claussen CD, Horger M. Vogel M, et al. Eur J Radiol. 2006 Dec;60(3):392-7. doi: 10.1016/j.ejrad.2006.07.013. Epub 2006 Aug 17. Eur J Radiol. 2006. PMID: 16916592

8

Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.

Bethge WA, Wilbur DS, Sandmaier BM. Bethge WA, et al. Leuk Lymphoma. 2006 Jul;47(7):1205-14. doi: 10.1080/00423110500485822. Leuk Lymphoma. 2006. PMID: 16923548 Review.

9

Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.

Schumm M, Handgretinger R, Pfeiffer M, Feuchtinger T, Kuci S, Faul C, Vogel W, Bethge W, Lang P. Schumm M, et al. Cytotherapy. 2006;8(5):465-72. doi: 10.1080/14653240600932787. Cytotherapy. 2006. PMID: 17050251

10

Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.

Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M, Handgretinger R, Kanz L. Bethge WA, et al. Exp Hematol. 2006 Dec;34(12):1746-52. doi: 10.1016/j.exphem.2006.08.009. Exp Hematol. 2006. PMID: 17157172 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page